COVID-19 Vaccine Monitor Dashboard

Latest Polling
43%
Black adults, along with young adults, are the most likely to say they want to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. 
36%
A third of those who have not yet been vaccinated have heard at least one of three inaccurate claims about the vaccine and either believe the misinformation or aren’t sure if it is true.
60%
Most U.S. adults who have not yet gotten vaccinated say they do not have enough information about when to get a COVID-19 vaccine once they are eligible. 
79%
Doctors, nurses, and health care providers are the source where most people say they will likely to turn for information when deciding to get a COVID-19 vaccine. 
NEW & Noteworthy
  • How Can Trump Administration Regulations Be Reversed?

    With the inauguration of President Biden and Democrats holding a slim majority in Congress, policymakers are likely to consider whether and how to reverse various health policy regulations issued by the Trump Administration.

  • OBGYNs and the Provision of Sexual and Reproductive Health Care: Key Findings from a National Survey

    This brief provides a status update on prescription drug final rules advanced by the Trump Administration in its final months related to Medicare, importation, and 340B pricing for insulin and epinephrine, and an overview of key drug pricing proposals related to Medicare and prescription drug prices generally that may return to the forefront of health policy discussions in the coming years.

  • New Incentive for States to Adopt the ACA Medicaid Expansion: Implications for State Spending

    The House Energy and Commerce Committee reconciliation proposal as part of the COVID relief package aims to encourage non-expansion states to take up the expansion by providing an additional temporary fiscal incentive for states to newly implement the ACA Medicaid expansion. This brief provides illustrative estimates of the net fiscal benefit to states from these incentives relative to state costs under the expansion.

  • COVAX and the United States

    This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX’s organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

Drew Altman, CEO

Chart of the Week

37 States Explicitly Outline What Conditions are Considered “High-Risk” for Vaccine Prioritization

Here’s a breakdown of how states are including “high-risk medical conditions” in their vaccination priority groups. Among the 50 states and DC, 37 have provided explicit information on what conditions they consider “high risk.” Learn more in this Chart of the Week.

Read More

Browse the Latest from KFF

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.